Patent · US Active

Covalently closed non-coding immunomodulatory DNA construct

US10280424B2 · kind B2 · utility

5Cited by

0References

5Claims

0Family size

Assignee

Mologen AG · DE

Inventors

Christiane Kleuss · Berlin, DE
Kerstin Kapp · Berlin, DE
Burghardt Wittig · Berlin, DE
Matthias Schroff · Berlin, DE

Key dates

Filing date	Feb 18, 2015
Grant date	May 7, 2019
Priority date	—
Expiry date	Feb 18, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a covalently closed DNA construct, a pharmaceutical composition and a vaccine and their use for the modulation of the immune system. It provides a DNA construct for immunomodulation comprising a specific DNA sequence.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.